The Arora Report

Rss Facebook Twitter Linkedin

Stock Market News To Give You An Edge

Proven Track Record of Most Accurate Analysis

Stock Market News
To Give You An Edge​

Proven Track Record
of Most Accurate Analysis

COMPLETELY INDEPENDENT AND OBJECTIVE

The Arora Report, Ltd. is a rare publisher that does not accept advertisements. This way The Arora Report can not be influenced. The Arora Report also does not accept payments from any company that is the subject of the posts. The Arora Report has forsaken millions of dollars in revenues to avoid conflicts of interest. Our sole job is to help you. Read more.

COMPLETELY INDEPENDENT AND OBJECTIVE

The Arora Report, Ltd. is a rare publisher that does not accept advertisements. This way The Arora Report can not be influenced. The Arora Report also does not accept payments from any company that is the subject of the posts. The Arora Report has forsaken millions of dollars in revenues to avoid conflicts of interest. Our sole job is to help you. Read more.

WHAT TO DO WITH 39 POPULAR STOCKS — NEW BUY ZONES AND TARGETS

November 19, 2025

By Nigam Arora The Arora Report released new buy zones for 39 widely followed stocks.  These powerful zones identify optimal entry points based on deep technical, fundamental, and macroeconomic analysis.  Market pullbacks create opportunities.  Investors who are prepared and who use buy zones maximize risk adjusted returns.   Opportunities For Tactical Positions The stock market has pulled back from all time highs.  The pullback is creating opportunities for tactical positions.    The year end chase could start driving the stock market.  Those who follow buy zones for great entry prices could be sitting on very nice returns come next year.   Building Wealth With

Read More »

NVIDIA EARNINGS WILL DETERMINE MARKET DIRECTION, HOME DEPOT SHOWS CONSUMER WEAKNESS, CHINA JAPAN FLARE UP

November 18, 2025

By Nigam Arora To gain an edge, this is what you need to know today. Key Earnings Data  Please click here for a chart of Nvidia stock (NVDA). Note the following: The Morning Capsule is about the big picture, not an individual stock.  The chart of NVDA stock is being used to illustrate the point. The chart shows NVDA stock has given up recent gains. The chart shows NVDA stock is at the top band of zone 1 (support). RSI on the chart shows NVDA stock is not yet oversold. Nvidia earnings will be reported tomorrow in the after market. As

Read More »

MINDLESS DIP BUYERS SAVE THE STOCK MARKET – HINDENBURG OMEN APPEARS

November 17, 2025

By Nigam Arora To gain an edge, this is what you need to know today. Dip Buyers Save The Market Please click here for a chart of Nasdaq 100 ETF (QQQ). Note the following: The chart shows QQQ was weakening going into Friday morning. The chart shows mindless dip buying saved the stock market. The chart shows that the morning today started with buying in QQQ, but as the morning has progressed, sellers have become dominant. The VUD indicator is the most sensitive measure of net supply and demand in real-time. The orange represents net supply and the green represents net

Read More »

WEEKLY STOCK MARKET DIGEST: WHAT PRUDENT INVESTORS NEED TO KNOW NOW

November 15, 2025

By Nigam Arora & Dr. Natasha Arora Weekly Digest from The Arora Report is popular among serious investors and money managers because they have found studying insights from the prior week gives them an edge over the coming weeks. Here is the day by day rundown from the morning capsules made available every morning before the market open in the Real Time Feeds to the paying subscribers of The Arora Report.  Please scroll down for the section ‘Protection Bands and What To Do Now.’   TECH STOCKS TUMBLE ON FEAR FED MAY NOT DO THE WRONG THING, $870M BITCOIN ETFS

Read More »

TECH STOCKS TUMBLE ON FEAR FED MAY NOT DO THE WRONG THING, $870M BITCOIN ETFS OUTFLOWS

November 14, 2025

By Nigam Arora To gain an edge, this is what you need to know today. Fed Fears Please click here for a chart of Nasdaq 100 ETF (QQQ). Note the following: The chart shows QQQ has dipped into zone 1 (support). The chart shows QQQ is making a lower low than the prior low. The chart shows that QQQ has very quickly given up the gains from the government opening euphoria. RSI on the chart shows QQQ is oversold.  Oversold markets tend to bounce. A pullback to the low band of zone 1 (support) and even a slight break is a

Read More »

COULD YOU HAVE SEEN ELI LILLY’S (LLY) RALLY COMING? HERE’S HOW WE DID.

November 13, 2025

By Nigam Arora On October 17th, our paid members were alerted that a major development on weight loss drug pricing was likely coming and that it could significantly impact Eli Lilly (LLY) stock. Yesterday, there was a signal in ZYX Buy on a key development that could materially impact LLY stock. Eli Lilly, one of the stocks in the ZYX Buy Core Model Portfolio by The Arora Report, has struck a deal with President Trump’s administration to lower the price of its weight loss drugs. Reduced pricing and expanded access, particularly through Medicare and Medicaid, are expected to drive significantly wider

Read More »

AMD WANTS TO TAKE AI SHARE AWAY FROM NVIDIA, BUYING ON GOVERNMENT OPEN CONTINUES, FED DIVIDED

November 12, 2025

By Nigam Arora To gain an edge, this is what you need to know today. AI Share Please click here for a chart of Advanced Micro Devices stock (AMD). Note the following: The Morning Capsule is about the big picture, not an individual stock.  The chart of AMD stock is being used to illustrate the point. The chart shows AMD stock trading in a wide range yesterday as the company conducted its investor day. The chart shows AMD moving up this morning. The price action in AMD is a learning moment for investors.  It is not how good the investor day

Read More »

CONGRATULATIONS! BIOTECH COMPANY METSERA (MTSR) BUYOUT BY PFIZER (PFE) BECOMES 217TH ARORA PORTFOLIO BUYOUT

November 11, 2025

By Nigam Arora Editor’s note: This post was published yesterday in The Arora Report paid feeds. 217th Buyout Novo Nordisk (NVO) and Pfizer (PFE) have been in a bidding war over biotech Metsera (MTSR).  Pfizer prevailed, making Metsera the 217th Arora portfolio company to be bought out. Late Friday evening, MTSR stock traded as high as $89 on expectations that Novo Nordisk would raise its bid.  When Novo Nordisk did not raise its bid, MTSR stock fell. The Deal The value of Pfizer’s offer is $86.25 per share.  The offer is for $65.60 cash and up $20.65 contingent value rights (CVR) per

Read More »

AI is power hungry. Investors will make a fortune from nuclear power for AI.
Get the list of 12 nuclear power stocks to grab your share of the profits.

AI is power hungry. Investors will make a fortune from nuclear power for AI.

Get the list of 12 nuclear power stocks to grab your share of the profits.

Big Tech is investing billions

Making A Fortune
In Nuclear Energy

Golden Age of Nuclear Energy

Skip to content